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I .  INTRODUCTION 
This study is an analysis of the costs and benefits of 
implementing the amendment to the interim primary drinking water 
regulations proposed by the Environmental Protection Agency in 
January, 1978 (EPA, 1978) . Specifically, the study will consider 
the benefits and costs involved for those water supply systems 
which would be required to remove organic contaminants by installing 
granular activated carbon (GAC) as a post- filtration adsorbent. 
This study builds upon and extends the partial analysis of 
these regulations conducted by the National Academy of Sciences 
(NAS) earlier this year (NAS, 1978) . In the words of one of the 
panelists , that study "should be viewed as a guide for the method­
ology of benefit-cost analysis and not as a complete and definitive 
study of the proposed EPA regulation of trihalomethanes . •·1 The 
NAS study is insufficient by itself for evaluating the proposed 
regulations for the following reasons : 
1 .  The only drinking water contaminant considered was 
chloroform; the effects of other chlorination by-products 
and synthetic organic chemicals were ignored. 
2. The surface area adjustment method which was used to
estimate the cancer risk associated with chloroform was
inconsistent with a previous NAS panel's recommended
method (NAS, 1975) , which yields a risk estimate approxi­
mately three to 15 times greater than the "upper limit" 
and "most probable" risk estimates, respectively , derived 
1 Letter from John Cumberland, University of Maryland , to Victor
Kimm , EPA , August 29 , 1978 .  
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from the surface-area method. 
3 .  The NAS study made n o  attempt t o  integrate evidence 
from epidemiologic studies in its derivation of risk 
estimates . 
4. The only methods of contaminant removal considered were
GAC adsorption and aeration, expensive methods which would
not be required for two of the three levels of contami­
nation dealt with in the study . 
5 .  The only benefit considered was reduced cancer death ; 
the prevention of other adverse health effects (mutagenic , 
teratogenic and fetotoxic) , reductions in anxiety about the 
health risks of contaminated drinking water , and improve­
ments in the taste and odor of tap water were not discussed.
6 .  Two important factors were excluded from the benefit-
cost analysis but must be discussed in evaluating the 
results : irreversibility and risk aversion. 1 
A second study, the Council on Wage and Price Stability ' s
1 In the same letter , op . cit .  Cumberland continues : "Since Chapter
8 referred to above was necessarily limited by data , time constraints, 
and other guidelines established for the considerations of the 
panel , some important aspects were necessarily omitted , and should 
be carefully considered in a complete evaluation. Among the additional 
important considerations which should be evaluated as the basis for 
any regulation are : 
1. benefits of removal of other THMs besides chloroform, 
2 .  benefits o f  removal o f  carcinogens which are not THMs , 
3 .  other benefits such as removal o f  mutagens , 
4 .  consideration of other means of removing THMs such as 
alternative forms of  disinfectants ,  and 
5 .  inclusion of other means o f  risk estimation , most importantly 
inclusion of the epidemiological evidence. " 
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(CWPS) "Analysis of Proposed EPA Drinking Water Regulations" follows 
in its essential respects the methodology of the NAS study. It 
furthers the methodology by developing estimates of incremental 
cost  for evaluation of the cost-effectiveness  of the regulations as 
a function of city size and pollution load. While this extension 
is a contribution , the main intention of the CWPS study was not to 
develop a methodology but to make realistic estimates of .cost per 
cancer prevented and from these to draw realistic policy recommenda-
tions . However ,  the same six limitations just ennumerated for the 
NAS study apply as well to the CWPS study, suggesting that CWPS 
has significantly underestimated the benefits associated with 
drinking water improvement.  Consideration of point two , for example , 
leads to a "cost  per life saved" on order of magnitude lower than 
estimated by CWPS.  
The study presented here will focus on water supply systems 
with contamination levels which may necessitate the use of GAC , 
and will be limited to communities large enough to be affected by 
the proposed regulations . The cancer risks associated with organic 
drinking water contaminants will be derived from the evidence of 
animal studies taken together with evidence from epidemiologic 
studies .  Additional benefits will b e  dealt with to some degree , and 
it will be explained how the consideration of factors additional to 
the results of the benefit-cost analysis should enter into the 
determination of  the economic evaluation of GAC . 
It is realized that this study will also have short-
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comings , particularly with regard to certain simplifying assumptions 
which were made . As more information is developed regarding the risks 
of contaminated drinking water , some of those assumptions may need 
revis ion. ·only a little will be said about irreversibility and social 
risk aversion. Neverthe less, it is hoped that this study will ,  at the 
very least ,  carry the analysis of the economic evaluation of the 
proposed regulations an incremental step beyond the NAS and CWPS 
analyses of the benefits and cost associated with chloroform reduction. 
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IL BACKGROUND 
Under the Safe Drinking Water Act of 1974 (PL 93-523) , 
the Environmental Protection Agency (EPA) is required to prescribe 
regulations for those contaminants which the Administrator deter­
mines may have an adverse effect on human health. Under Section 
1412 (a) (2) , these contaminants are to be controlled "to the extent 
feasible, . . (taking costs into consideration) . The 
Congressional intent is strongly preventive ; conclusive proof 
of an advers e  health effect is not a prerequisite to regulation 
(United States Congress , 1974) . 
The Organics Problem 
Recent research has demonstrated that organic contaminants 
potentially harmful to human health are ubiquitous in America's 
drinking water . Over 700 such contaminants have been identified , 
yet they represent only about 15 percent by weight of the total 
organic matter in drinking water (EPA, 1978a; NAS , 1977) . }fany 
contaminants cannot be identified and/or quantified given present 
analytical methodologies . 
Only a small fraction (less than 10 percent) of the known 
contaminants have been adequately tested for adverse health effects . 
A recent listing by the National Cancer Institute (see Appendix A) 
identified 23 chemicals as known or suspected carcinogens , 30 
chemicals as known or suspected mutagens , while 11 chemicals were 
identified as tumor promoters (i . e . , substances which are not in 
themselves carcinogens but which interact with carcinogens to 
enhance the rate of tumor formation) . In addition , some drinking 
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water contaminants are known to be teratogenic (cause birth 
defects) or fetotoxic (result in fetal deaths or stunted growth) 
(NAS , 1977 ) . 
Although observed concentrations of specific contaminants 
range from approximately one part per million to five parts per 
trillion (lowest detectable level) (EPA , 1978 and 1977 ) ,  con-
centration levels are meaningless without knowledge of potency. 
For example , there is more than a 100 millionfold range in the potency 
of carcinogens in tests on rodent s . 1 This means that one part
per trillion of one of the most potent carcinogenscan cause as 
much cancer in rodents as one part per million of one of the 
weakest carcinogens . Most of our knowledge about relative 
potency comes from animal studies and, while there is much to be 
learned about interspecies comparisons , it is worth noting that 
animal studies have shown that chloroform, the most prevalent 
carcinogen in drinking water, is only moderately potent in rodents , 
and many of the chemicals present in much lower concentrations 
are far more potent . Dieldrin , for example , which is generally 
present in far lower concentrations than chloroform, is 1 , 500 
times more potent than chloroform in mice (NAS , 1977 ) ,  and wha-i 
all rodent species are considered the difference is over 3 , 000 fold. 
1 Based on the work of Sawyer ,  Hooper , Friedman and Ames , in 
preparation , cited in Mccann, 1977 . 
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Furthermore , the total risk associated with exposure 
to multiple carcinogens may be far greater than the sum of the 
risks posed by each chemical individually , due to synergistic 
interactions between carcinogens . Exposure to promoters might 
also enhance the carcinogenic effect of chemicals in drinking 
water compared to the effect of single chemicals in rodent studies, 
A s ingle promoter has been shown to intensify the effects of 
a particular carcinogen by a factor of 1 , 000 (Bingham and Falk , 
1969) . In addition , the effects of drinking water contaminants 
may be potentiated by other exposures to carcinogens and promoters 
(e. g . , from food , air pollution and smoking) , a particular problem 
for people living in urban areas or exposed to occupational car-
cinogens . 
Thus , organic contaminants pose a potential threat to 
health today and in the future . The effects of exposure to 
carcinogens have a typically long latency; the time elapsing 
between exposure and clinical symptoms of the disease is often 
as much as twenty to forty years , depending ill some occasions 
upon the level of exposure . Drinking water contamination has 
been consistently linked to gastrointestinal (GI) and urinary 
tract (UT) cancer , although associations with other sites (e. g . , 
lung, brain) have been observed. 1 Mutagens are a suspected
1 Eleven epidemiologic studies have shown significant associations
between cancer mortality , principally GI and UT , and chlorinated or 
surface waters . A twelfth study failed to identify positive 
associations , but it was beset by methodological problems , primarily 
p0pulation migration . Letter of Dr . Arthur C. Upton , Director , 
National Cancer Institute , to Dr. Douglas M. Costle , Administrator , 
Environmental Protection Agency, April 10 , 1978 . Chlorinated 
drinking water was associated with elevated rates of lung cancer 
in Alavanja,  et al . ,  1977 ; and Cantor , et al . , 1977; and with brain 
cancer in Cantor , et al . ,  1977 . 
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causal factor in atherosclerosis; and they are capable of causing 
subtle biochemical changes ,  some of which may affect health today 
in unknown ways , and some of which may not be expressed for several 
generations . Even less is known about the extent to which drink­
ing water contaminants may contribute to fetal deaths, stunted 
growth and birth defects , although a recent study suggests this 
may be a potential problem (McKinney , et al. , 1976 ) . 
While efforts are continually being made to estimate 
the risks to human health posed by these chemicals , such estimates 
are highly uncertain. Both means of determining cancer risks-­
animal experiments and human epidemiologic studies--have consider-
(as opposed to ground water) , which is the source for most urban 
areas (there are notable exceptions , e . g . , Miami) . Although 
the proposed regulations distinguish between THMs and other 
organics ,  contaminated surface waters are likely to contain 
certain amounts of both types of organics .  
Regulatory Approach 
The proposed regulations consist of two parts , addressing 
both types of organics: 
1. A maximum contaminant level of 100 parts per billion
able limitations , and the methodolgies used to establish mutagenic 
(ppb) was proposed for THMs , since they are present 
and teratogenic effects may be even less applicable to man than 
in the greatest concentrations and can be easily 
animal cancer tests (NAS , 1977  ) .
quantified. 
2 .  The treatment technique of GAC adsorption , or its 
Sources of Contamination equivalent , will be required to reduce synthetic 
The major sources of organic contamination are synthetic 
organic chemicals which enter the water supply via municipal 
and agricultural runoff , industrial discharges and chemical spills; 
and natural organic matter resulting from the decomposition of 
plants and animals .  When chlorine disinfectants are added,  they 
interact with the natural organic matter and form a host of chlori­
nated and brominated compounds . The four trihalomethanes (THMs) -­
chloroform, bromoform, dibromochloromethane and bromodichloro­
methane--are a particular subgroup of these compounds, and they 
are usually the most prevalent organic contaminants in chlorinated 
drinking water so far identified. 
Organic contamination primarily affects surface water 
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organics as a group . Because they are so numerous 
and because their concentrations and chemical charac­
teristics make detection difficult , regulation of 
individual chemicals was considered infeasible. 
The THM standard can be met in a variety of ways . Depend­
ing on the types and amounts of natural organic matter , THMs 
may be reduced by using alternative disinfectants; by chlorinat­
ing after coagulation , sedimentation, and sand filttration have 
removed the natural organic precursors; or some combination of 
these. These solutions are relatively inexpensive compared to 
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GAG. For water supply systems with 25 0ppb or more of THMs , however , 
GAG adsorption may also be necessary. GAG has the additional 
advantages of removing synthetic organics and natural organics 
other than THMs , as well as unpleasant tastes and odors resulting 
from organic contaminants and their interactions with chlorine . 
The proposed regulations are to be applied initially to water 
systems serving populations of 75 , 000 or greater . Administrative 
and economic considerations were the primary reasons for this 
decision. Only 1 percent of public water systems are in this s ize 
range (390 out of 40 , 000) , yet they serve approximately 52 percent 
of the population (EPA, 1978) . Lowering the s ize of communities 
subject to the regulations would greatly increase the number of 
systems involved and thus increase the difficulty of monitoring . 
Also , due to economies o f  scale , GAG adsorption is relatively 
more expensive (on a cost-per-gallon treated basis )  for smaller 
systems than for larger systems . 
Of the 390 municipal water systems subject to the proposed 
regulations , an estimated 121 will not meet one or both of the 
proposed standards (TBS , 1978) . Of these systems , 6 1  will be 
required to install GAG: 11 to meet the THM standard ,  35 to meet 
the synthetic organics standard , and 15 to meet both standards . 
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III . BENEFITS OF REMOVING ORGANIC CONTAMINANTS FROM 
DRINKING WATER 
Removal of organic chemical contaminants from drinking 
water has been associated with the following benefits : 
* Prevention of cancer death 
* Prevention of non-fatal cancer illness
* Prevention of mutagenic ,  teratogenic and fetotoxic effects
* Reduction of the anxiety caused by knowing that drinking 
water poses risks to health
1 
* Improvements in the taste and odor of tap water 
While some of these benefits would be expected to accrue immediatel,y 
after GAG is installed, their full impact would not be realized 
until some future time . Since an individual exposed to a carcino­
gen may bear an increased risk of cancer throughout his lifetime , 
the benefits of GAG may not be fully realized until all persons 
exposed to drinking water contaminants are no longer living , 
assumed in this study to be 70 years . 
The number of non- fatal cancer illnesses which might be 
prevented annually will depend upon the extent to which various 
cancer sites are affected. As discussed below, this number may 
be as much as one-half the number of deaths which might be 
prevented annually, although this estimate is highly uncertain. 
The extent to which mutagenic , teratogenic and fetotoxic effects 
will be prevented is unknown . 
1 Anxiety is listed separately because under both the willingness­
to-pay and the lost earnings approaches this component of cost 
is often excluded. See Appendix D. 
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The Risk of Cancer Posed by Organic Contaminants 
In Drinking Water 
Cancer causes approximately 365 , 000 deaths annually in 
the United States , and about 650 , 000 new cases of cancer (exclud­
ing skin cancer) are detected each year. Gastrointestinal 
(GI) and urinary tract (UT) cancers, to which organic drinking 
water contaminants have been most consistently linked , comprise 
about 30% of total cancer illness  and death, or about 200 , 000 
new cases and 115 , 000 deaths per year. 1 While cancer survival 
rates vary with site and over time , and data limitations make 
estimates of survivors imperfect , an estimated 60, 000 (30%) of 
the 200 , 000 annually detected cases of GI and UT cancers would
ultimately be non- fatal, 2 if present survival rates continue
(see Appendix C) . The annual number of newly detected non-fatal 
GI and UT cancers thus appears to be about half the annual number
of deaths from these cancers . 
While the extent o f  excess cancer associated with organic 
contaminants is unknown , considerable evidence is available which 
suggests the range of possible risk. (See Appendix B for a 
discussion of the methods and limitations of human risk assess-
1 These figures were based on the following data : (1) estimated
resident U. S .  population of 2 1 7 , 599 , 000 as of April 1 ,  1978 (source : 
U . S .  Bureau of Census, Estimate o f  Po ulation of the United States 
to A§ril 1, 1978 , Series P-25 , No . 724) ; 2 annual incidence rates
of 3 00 per million population for all cancer , and 929 for GI and 
UT cancer (source: NCI , 1976 ) ; and (3) annual mortality rates of 
1673 per million population for all cancer, and 536 for GI and 
UT cancer (source: NCHS , 1977) . 
2 Survival rates tend to stabilize between 5 and 10 years after
detection of the disease .  For individuals surviving after 10 
years, the disease could be considered to have been non- fatal . 
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ment . ) Since this study will consider the expected benefits 
and costs involved with the reduction in cancer mortality after 
the removal of THMs and s ynthetic organics, an attempt was made 
to select risk estimates reflecting the range suggested 
by this body of evidence1 from animal and short-term tests , as 
well as epidemiologic studies . 
Unfortunately, the epidemiologic studies which 
relate excess cancer mortality to the sources of drink-
ing water (surface, ground, etc. ) do not distinguish the possible 
effects of THMs from those of synthetic organics which may have 
been present . While water has been chlorinated since approxi­
mately 1910, many synthetic organics are of recent origin. During 
the " chemical revolution" o f  the past 30 years , the annual pro­
duction of synthetic organic chemicals increased from approxi­
mately 5 billion to 50 billion pounds per year. Given a probable 
20- to 4G-year latency for most chemical carcinogens , it is 
likely that most of the e ffects o f  synthetic organics are not 
yet expressed in total U . S .  cancer rates (see Figure 1 ) . Those 
synthetics which have been present long enough to affect current 
cancer rates may have had minor impact in comparison to the THMs 
(Harris, et al . ,  1977) . Hence currently observed excess cancers 
demonstrated in epidemiologic studies may be primarily the result 
of chlorination by-products and may not reflect the risk from. 
'xposure to current levels of synthetic organics .  
Chlorinated and brominated organic compounds, including 
those which form following chlorination and those 
-13-
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Figure 1. 
CANCER MORTALITY RATES AND CHEMICAL 
PRODUCTION AS A FUNCTION OF TIME
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Source: Harris, R.H. , T. Page and N.A. R eiches, "Carcinogenic 
Hazards of Organic Chemicals in Drinking Water," in Origins of 
Human Cancer, ed. H. D. Hiatt, J.D. Watson and J.A. Winsten, Cold 
Spring Harbor Laboratory, Cold Spring Harbor, New York, 1977. 
which are man-made, are not naturally found in mammalian meta­
bolism. Since their chemical properties make them or their 
metabolic intermediates prone to interact with genetic material 
(DNA) , it is perhaps not surprising that a high percentage 
of these compounds have been shown to be carcinogens and/or 
mutagens (Ames , 1977) . 
Chlorination by-products form continuously over time after 
chlorination , and it is not possible to make unambiguous state­
ments about the mix of compounds to which the public is exposed . 
The concentration and mix of THMs to which the public is 
exposed is also dependent upon the manner in which the water is 
used and processed in the home (heated or boiled for cooking, 
tea , coffee , etc. ) ,  as suggested in Table 1. In general, 
however , it appears that THMs constitute only 1/10 to 1/5 of 
the total chlorinated organic compounds (see Table 2) . The 
non-THM fraction has yet to be adequately characterized. 
Knowledge about chlorination by-products is sparse and may be 
briefly summarized as follows : 
1 .  Only one o f  these compounds , chloroform ( a  THM) , has 
been adequately studied in animal cancer tests , and 
it is a moderately potent carcinogen in rodents (see 
Figure 2 ) .  
2 .  A short- term cancer test (lung adenoma assay) for 
several drinking water contaminants, including all 
four THMs, showed unambiguously positive results only for 
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Table 1 
Percentage Increase or Decrease of Three THMs Above or 
Below Levels Present in Cincinnati Cold Tap Water 
Cold Boiled Boiled Hot 
Compound Tap 5 Sec . 30 Min . Tap 
Chloroform 
Bromodichloromethane 
Dibromochloromethane 
0 
0 
0 
(+) 96 . 5  (- )94 . 0 
(+) 72 . 4  (- ) 97 . 2  
(+)121 . 9  (- ) 100.0 
(+) 108 .  0 
(+) 78 . 6
(+) 141 . 9 
Source: Melton, R. , et al. , "The Analysis of Purgeable Organics 
in the Drinking Water<:irFive U. S .  Cities , "  U . S . E . P . A . , June , 
1975 . 
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TABLE 2 .  
COMPARISONS BETWEEN TOTAL CHLORINATION BY-PRODUCTS 
AND TRIHALOMETHANES (THMs) 
Chlorination of Ruhr River Water1
Species 
TOCl* 
Chlorof orm 
THM 
Increase (ug/l) 
186 
6 
14 
I 
� Chlorination of Hutnic Acid (2 tng/1)2 
Species 
TOCl* 
Chlorof orm 
*Total organic chlorine.
3. 8 mg/l Cl2(ug/1) 
198 
39 
19.4 mg/l Cl2(ug/l) 
278 
32 
1source: Sontheimer, H. , E. Heilker, M. Jekel, H. Nolte and
F.G. Vollmer, "The 'Mulheim Process' -- Experience With a New
Process Scheme f or Treating Polluted Surf ace Water", Journal of 
American Water Works Association, in press. 
2source: Stevens, A., Environmental Protection Agency,
personal communication, May 26, 1978. 
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RELATIVE CARCINOGENIC POTENCY 
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1chloroform ,. saccharin and TCDD ' (dioxin) .added, Robert H. Harris, 
unpublished data (1978). 
Source: J. McCann, Summary of testimony given before Senator Edward 
Kennedy's Health Subcommittee Hearing on saccharin, June 7, 1977. 
bromoform, while chloroform yielded negative results 
(Theiss ,  et al . , 1977) .  This is consistent with the 
general observation that brominated analogues are 
Therefore , chloroform may be the "tip of the iceberg" 
with respect to the cance'r hazard posed by chlorination. Chloro­
form appears to be only a moderately potent carcinogen, and if 
usually more potent carcinogens than the chlorinated species . it is a mutagen , it may be only weakly so in comparison to the 
The negative result on chloroform cannot be interpreted 
to mean that chloroform is not carcinogenic , since the 
lung adenoma assay is a relatively insensitive test 
for chemical carcinogens . 
3 .  Short-term mutagenicity tests (Ames test) demonstrated 
that all THMs except chloroform.were mutagenic and 
1 
therefore probably carcinogenic (Simmon, et al . , 1977) . 
4 .  Ames tests conducted on the non-THM component demon­
strated substanial mutagenic activity in comparison 
to the same water before chlorination (Hooper et al . , 
1977) . 
5 .  Similar studies have demonstrated mutagenic activity 
of raw surface waters (Pelan , 1976) and of organic 
non-THM concentrates of finished drinking water 
(Loper, et al. , 1977 ) . Although precise estimates have 
not been made , the mutagenic activity of the non-THM 
fraction would appear to be in the same range as the 
rnutagenic activity of the THM fraction. 
1 It must be noted that the Ames test does not yield positive 
results for several heavily chlorinated compounds shown to be 
carcinogenic in animal tests , including chloroform, carbon tetra­
chloride and dieldrin (!1cCann , et al., 1975) . 
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other THMs . It thus appears that the carcinogenic potential 
of THMs is likely to be much greater than that of chloroform 
alone ; indeed , chloroform may be of lesser importance than the 
other THMs even though it is usually present in higher concen-
trations . Furthermore, the non-THM , chlorinated component is 
clearly mutagenic and probably carcinogenic. This evidence 
suggests that the cancer risk resulting from chlorination may 
be grossly underestimated if the risk estimate is based on 
chloroform alone. 
Risk Estimates Based on Animal and Epidemiologic Evidence 
As noted above , both animal and epidemiologic studies have 
limitations for use in human risk estimates .  (These limitations 
are discussed more fully in Appendix B . ) Animal tests yield 
varying results and are beset by uncertainty in converting to 
human risk esti�ate s .  Epidemiologic studies cannot control 
for all possibly confounding factors and ,  in the case of 
drinking water , suffer from the absence of exposure data several 
decades ago . Also , only case-control studies , as opposed to 
ecologic (whole population) studies, are generally considered 
appropriate for yielding precise risk estimates , although 
ecologic studies can be interpreted in a manner which sheds 
-20-
some light on risk. Only one case- control study has so far been 
completed on the association between organic drinking water con­
taminants and GI and UT cancer (Alavanja, et al . ,  1977) . 
Estimating risk based on animal studies is constrained by 
the paucity of data on the carcinogenicity of chemicals identified 
in drinking water; less than 10 percent of these chemicals have 
been tested for their potential carcinogenicity. Furthermore , 
there is no generally agreed-upon method for extrapolating risk 
from animal experiments to humans . Despite these limitations , 
risk estimates were made for those few carcinogens in Miami and 
New Orleans drinking water (both highly contaminated) for which 
animal data and monitoring data were available . Two generally 
accepted and conservative (yielding higher risk estimates) 
methods of risk estimation were used: (1) a linear 
surface-area method used by the NAS drinking water committee 
(NAS , 1978) , and (2) a linear lifetime accumulated-dose method 
recommended by the NAS pesticide committee (NAS , 1975) . This 
latter method is based on a study of six human carcinogens , while 
the former is based on theoretical and empirical considerations 
of chemical carcinogenesis and mammalian metabolism. 
The total risk estimations for New Orleans (Table 3) are 
approximately 23 and 102 cancers/million population/year; for Miami 
(Table 4) they are approximately 19 and 34 cancers/million popu-
lation/year , using the surface-area and lifetime- dose methods , 
respectively. It must be emphasized, however , that these risk 
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estimates are both incomplete and possibly misleading; the con­
centration of each carcinogen listed in Tables 3 and 4 is based 
on limited sampling data and there were present in both waters 
several additional carcinogens (see Table 5 )  for which either 
the exposure or carcinogenicity data were not available . 
Based on the lifetime accumulated dose method , which produces 
the higher risk estimate , it can also be calculated that for a 
THM level of 250ppb , a THM level above which most utilities would 
probably require GAC to meet EPA's proposed THM standard of lOOppb , 
the risk estimate would be approximately 20 cancers /million/year . 
This contrasts with a risk estimate o f  12 cancers /million/year 
using the estimate of the NAS drinking water connnittee , and 1 . 4  
cancers/million/year using CWPS ' s  estimate . These all assume that 
the aggregate THM's are equivalent in potency to chloroform, an 
assumption which is likely to result in an underestimate of the 
risk s ince , as discussed above , the brominated THM's are likely 
to be more potent carcinogens than chloroform. 
Epidemiologic studies suggest substantially higher risks 
from drinking chlorinated water} In a recent policy statement , 
the National Cancer Institute (NCI)  referred to one ecologic 
study which implied that reducing chloroform by 250 ppb would 
result in percentage reductions in combined large intestine and 
bladder cancer mortality equivalent to approximately 45-110 deaths 
1 It should also be noted that the epidemiologic studies have 
focused on risk of mortality while the animal studies have focused 
more, though not entire ly, on incidence. However , the difference 
between mortality and incidence is relatively small (roughly a factor 
of two) compared with the range of risk estimate (one or two orders 
of magnitude). See Appendix c. 
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TABLE 5 
SELECTED CARCINOGENS* AND MUTAGENS FOUN� IN 11-CITY SURVEY 
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per million population per year . 1 Another ecologic study using
a slightly different data base showed significant associations 
with additional cancer sites , implying that the excess deaths 
might be somewhat greater (Cantor , et al . ,  1977) . 
Two ecologic studies involving 88 Ohio and 64 Louisiana 
counties suggested that contaminated surface water was responsible 
for approximately 8% and 15% ,  respectively, of the total 
cancer mortality rate. 2 Given the total United States annual 
cancer mortality rate of about 1673 per million , these studies 
imply that contaminated surface water similar to surface water 
in these two states may be responsible for between 135 and 250 
cancer deaths per million annually. Although there is insufficient 
data on the quality of the water included in these studies to 
determine the average exposure to the communities involved, it 
appears that the risk estimates suggested by these studies are 
not unreasonable for drinking water with 250 'ppb of Tl:!Ms as well 
as synthetic organic chemicals of industrial origin. Data on 
1Letter of A. C .  Upton to D . M. Costle, April 10, 1978 . As the 
letter noted , one ecologic study implied that reducing chloroform 
by 100 ppb would result in the following percentage reduction 
in cancer mortality : bladder , 1 . 3%- 7 . 5% for males and 5 . 3%-10 . 0% 
for females ; large intestine, 4 . 0%-8 . 5% for males and 3 . 0%-
7 .  5% for females . To calculate the reduction in 
cancer mortality from a 250 ppb reduction of chloroform, these 
percentages were multiplied by 2 . 5  and then applied to the U . S .  
cancer mortality rates , per million population : bladder , 6 1 . 7 
for males and 2 1 . 0 for females ; colon/rectum, 222 . 0  for males 
and 231 . 0  for females (NCHS, 1977) . 
2see Page, et al . ,  1976 , and Harris, et al . ,  1977 . The 
percentages given in those sources cover a broader range , but 
they refer to specific sex and ethnic groups . 
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Cincinnati tap water from the Ohio River (taken prior to the 
alteration of chlorination procedures )  indicate that THM levels 
ranged from approximately 70-280 over the course of the year , 
while a one-time reading taken in the fall from the treatment 
plant for New Orleans indicated THM levels of approximately 
140 ppb , and summer readings taken from the distribution system 
ranged from 170-250 ppb . 1 
A 1977 case control study of cancer rates in seven New 
York counties (Alavanja, et al . ,  1977) indicated that urban 
areas served by chlorinated water supplies have combined GI 
and UT cancer rates 2 . 7 times higher than urban areas with non­
chlorinated supplies ; in rural areas , the cancer rate is 1 . 8  
times higher for chlorinated supplies . (It is not known to 
what extent these higher rates are associated with the level 
of chlorination by-products , other drinking water contaminants ,  
or possibly other unforeseen factors . )  Using the nationwide 
combined GI and UT cancer rate of 536  per million as an estimate
of the rate for areas served by chlorinated water supplies, the 
above findings suggest that 2 38-335 excess deaths per million 
population annually are associated with chlorinated drinking water . 2 
These estimates , together with the estimates derived above are 
sunnnarized in Table 6 .  
1 Data on Cincinnati tap water were provided by A. Stevens , 
Environmental Protection Agency, Cincinnati, Ohio , personal 
connnunication, July 11 , 1978; data on New Orleans were taken from 
EPA, 1975 (fall reading) and B .  Lykins, Environmental Protection 
Agency, Cincinnati, Ohio, personal communication , July 12, 1978 
(summer readings) .  
2 The numbers inferred from the above studies are not precise , 
since the cancer data are based on age-standardized rates . 
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TABLE 6 
SUMMARY OF RISK ESTIMATES 
FROM ANIMAL AND EPIDEMIOLOGIC STUDIES 
ANIMAL MODELS 
Cancers/Million/Yr 
Surface-Area 
Method 
Lifetime 
Accumulated 
Dose Method 
New Orleans 
Miami 
Chloroform at 250 ppb 
EPIDEMIOLOGIC MODELS 
23  
19  
12  
102 
34 
20 
Cancer Deaths/Million/Yr 
Ohio (Surface vs . Ground) 140 
Louisiana (Miss . R. vs Ground) 250 
Chloroform 80- City Survey 
(250 ppb) 45- 110 
New York Counties 
(Chlor. vs Non-chlor. ) 240- 340 
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Selection of Risk Estimates for This Study 
The epidemiologic studies suggest risks between one and 
two orders of magnitude greater than those suggested by animal 
studies for chloroform alone . In both the NAS and CWPS 
studies epidemiologic evidence was omitted. But in a submission 
to EPA concerning the proposed regulations , the National Cancer 
Institute incorporated risk estimates based upon an epidemiologic 
study. To be conservative all the available information must be 
considered. In fact there are some suggestions that the 
epidemiologic studies are more reliable than the animal studies: 
1. Epidemiologic studies reflect the combined effect of all 
the chemicals in the water , including promotional and interactive 
effects ; such effects are missed in animal studies based on 
single chemicals .  Epidemiologic studies include the effects of 
yet unidentified carcinogens , while animal studies deal with a 
far smaller number of identified chemicals . 
2 .  There is a large disparity between animal doses and 
human exposures--a  3000 to 4000 fold difference in the case of 
chloroform. The range of extrapolation for chloroform in water 
is greater than for a similar extrapolation leading to the risk 
assessment of chloroform in toothpaste or cough syrup , for 
example , and makes the risk assessment for the effects of 
chloroform in drinking water less certain than for extrapolations 
over a shorter range . 
3 .  Confidence in the risk estimates derived from 
epidemiologic studies increases when consistent results are 
-29-
obtained from repeated suudies . To date, approximately 12 
epidemiologic studies have shown a reasonably consistent 
pattern of association between GI and UT cancer mortality
rates and drinking water contaminants , particularly when 
the power of the statistical methods used in the epidemiologic 
studies are considered (Harris et al.  1977). 
At the same time there are some suggestions that the 
epidemiologic studies may be less reliable than the animal 
studies: 
1. Epidemiologic studies , especially ecologic ones , 
cannot control for all possible confounding variables . This 
limitation might lead to either too high or too low estimates 
of risk. 
2 .  The data are likely to incorporate more errors of 
measurement than in the laboratory conditions of animal studies . 
3 .  Epidemiologic studies are to some extent weakened 
by migration, which tends to randomize the results (and 
decrease observed levels of significance) . 
It is not the purpose of this study to referee between the 
two sources of information and conclude that one is so much 
better than the other that one should be used and the other 
discarded entirely. A conservative approach suggests that a 
range of risk estimates be used, with the epidemiologic 
estimates at the higher end and the animal studies at the lower 
end. As noted , there is about one order of magnitude 
difference between the risk estimate based on lifetime 
accumulated dose (20) and the risk estimate based upon the 
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epidemologic studies of the Mississippi River and chlorinated 
drinking water in New York State (300) . Realistically this is 
about as narrow a range as could be estimated ,  given the 
uncertainties associated with each method of risk assessment 
discussed above . From this perspective the estimates derived 
from the two methods (20 and 300) are well within the bounds 
of uncertainty and the two methods are not incompatible . 
It may also be noted that the high estimate may be 
oriented s lightly toward organics besides THMs (including 
THMs as well) to the extent that the epidemiologic studies 
have picked up the effects of exposure to other chemicals as 
well as THMs (as mentioned previously many of the non-THMs 
are of recent origin and may not be reflected in the 
epidemiologic studies) .  And the low end of the estimate may 
be oriented toward the effects of THMs , as the low estimate 
is based upon chloroform and the assumption that other THMs 
are in the aggregate as potent as chloroform . Control for 
the THM standard is less expensive but does not insure against 
other organics which might be incorporated in the high risk 
estimate . On the other hand GAC removes a broad spectrum of 
organics and includes an insurance aspect , by controlling not 
only organics existing 20 to 40 years ago and hence included 
in the high risk estimate , but also newer organics which were 
not included in the epidemiologic estimates of risk . 
Thus neither is the 20 a lower bound nor the 300 an upper 
bound on the risk assessment . Reliance on the "most probable" 
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risk based on the surface-area method would have produced an 
estimate of approximately 1 cancer per million (CWPS ' s  estimate) . 
There appears to be no decisive scientific basis to choose 
between the two NAS recommended extrapolation techniq ues , so 
that the higher estimate (leading to 20) was chosen to be on 
the conservative side and to reflect the likelihood that the 
brominated THMs are considerably more potent (on the order of 
10- 100 times) than chloroform ; and that the THMs may represent 
as little as 10 percent of the total chlorinated organics 
resulting from chlorination. 
Therefore the risk estimates selected for this study are: 
Level 
of Risk 
Low 
Medium 
High 
Annual Number of 
Excess Cancer Deaths 
Per Million Population 
20 
150 
300 
Since the average annual cancer mortality rate is about 
1673 per million population for all cancers and 536 for GI and 
UT cancer , these low, medium and high risk factors would imply
that drinking water carciongens are responsible for about 1% , 
9% and 18%, respectively , of total cancer mortality, or 4% , 28% 
and 56% of GI and UT cancer mortality , in those communities
whose drinking water has the above characteristics . l 
The low (20 deaths per million) estimate of risk is based 
on the experimental animal (mouse) most sensitive to chloroform ; 
the medium (150 deaths per million) estimate of risk is a mid­
point between the low and high estimates ; and the high (300 cancer 
1 These percentages are based upon current cancer rates . If total , 
GI, and UT cancer rates double in the next forty years , these 
estimated percentages would halve . 
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deaths per million) is based on the epidemiologic studies of 
chlorination in New York State and of Mississippi River water 
in Louisiana. In neither of these latter studies was it possible 
to separate the risk from exposure to THMs from the risk from 
exposure to synthetic organics . In the New York study , the 
apparent risk from chlorinated water may be confounded by the 
association of chlorination with the presence of synthetic 
organics ;  in the Louisiana study , both THMs and other synthetic 
organics were present in the analysis conducted in 1974 (EPA , 
1975) . The extent to which they were present in the 1930s and 
1940s , and thus expressed in the 1950-1969 cancer rates upon 
which the epidemiologic studies were based, can only be speculated. 
However,  given the recent origin of most synthetic organics , 
and the 20- to 40 -year lag before the effects of newly introduced 
chemicals would be reflected in cancer mortality rates , it is 
quite possible that synthetic organics contribute little to the 
risk estimates derived from the New York, Louisiana and Ohio 
studies . The calculated benefits of GAC treatment, which are 
based on these risk estimates ,  may reflect only the benefits 
of reducing chlorination by-products ; the benefits of removing 
synthetic organics would be largely excluded.  Therefore , to 
the extent that synthetic organics pose a health hazard , the 
benefits of GAG treatment calculated from these risk estimates 
are underestimated (when GAG is required to IIEet only the THM standard) . 
In addition to fatal cancer illnesses , drinking water 
carcinogens would also be expected to cause non- fatal cancer 
illnesses . For example , about 5 1% of bladder cancer victims 
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survive , as compared to 1% for victims of pancreatic cancer 
(see Appendix C) . If all the excess deaths associated with 
drinking water were due to bladder cancer , the amount of non­
fatal illness would be far greater than would be the case if 
the excess  deaths were due solely to pancreatic cancer . As 
noted earlier , the annual incidence of GI and UT cancer cases
which may be considered non- fatal is about half the number of 
annual deaths from these cancers . If it can be assumed that 
excess cancers caused by drinking water carcinogens are GI 
and UT ,  and that all of these cancers are increased to the
same degree , then drinking water carcinogens may be responsible 
for an annual number of non- fatal illnesses approximately half 
the number of excess deaths . However ,  since it is unknown 
whether or not these assumptions are justified,  any estimate of 
non-fatal illness  associated with drinking water contaminants 
would be uncertain. Although the cost of non-fatal illness is a 
substantial fraction of the cost of mortality , the d�fference 
in the range of risk e stimate , between 20 and 3 0 0  per million, has
almost  certainly a larger impact on the estimated benefits of water 
treatment than does the inclusion of the benefits of morbidity 
reduction. For this reason we will not attempt to quantify the 
cost of non-fatal illness ,  except to note that it is substantial . 
A more refined cost-benefit analysis should include this benefit, 
as far as possible . 
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V. METHODS FOR EVALUATING BENEFITS AND COSTS 
Sections III and IV indicate that , primarily because of cancer 
latency , the distribution over time of the benefits of GAC differs 
markedly from the distribution of costs over time . When such 
significant distributional impacts occur, the problem of a fair 
distribution across time , or intertemporal equity , arises . This 
problem is especially important when the distributional impact 
spans several generations ,  as is the case with GAC , and the problem 
is intensified when human lives are involved.  Accounting for 
distributional or equity effects in a satisfactory way is no easy 
matter, either in the intratemporal setting or in the intertemporal 
setting (see Harberger, and Mishan and Page) . In the latter 
case ,  where there is the problem of determining the fair distribu-
tion of  costs and benefits across generations , economists have 
offered several approaches :  
1 .  Use a zero discount rate. This approach has been recom-
mended by Ramsey (1928) , Solow (1974a) and discussed by Mishan and Page ( l979)  
Although highly respected economists have favored this approach , 
it has received little application in actual cost-benefit analysis 
partly for the reasons discussed in Page (1977) . 
2 .  Use a rate of discount lower than the marginal productivity 
of capital. A 5 percent discount rate was used by d ' Arge in his 
analysis of the ozone depletion problem. The case of ozone deple-
1 As expressed by Solow (1974b) , " In social decision-making , however , 
there is no excuse for treating generations unequally and the time­
horizon is or should be very long . . . we ought to act as if the 
social rate of time preference were zero (though we would simultaneously 
discount future consumption if we expect the future to be richer than 
the present) . "  
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tion is structurally similar to the case of GAC in that the esti­
mated costs of ozone depletion were delayed nearly a century , due 
to physico-chemical latencies (low diffusion and reaction rates ) .  
In order to be "fair" to the future , d ' Arge recommended a low 
(5 percent) discount rate . 1 
3 .  Compare steady state costs and benefits . Approximately 
the first 70 years after the installation of GAC can be considered 
a "transition period" during which the cancer rates are adjusting 
downward ; in this period,  the benefits of GAC are growing while 
the costs remain relatively constant (in real terms) . After 70 
years , the ratio of benefits to costs will be fairly steady for 
the forseeable future.  As a way of taking into account the future ' s
perspective , which is "permanent" (or at least longer term than 
the transition period) , evaluation can be based upon this compari­
son of benefits and costs in the steady state . This is another 
way of being " fair" to the future ' s  interests . 
The steady state approach was used in the NAS and CWPS report on the 
benefits of  removing chloroform from drinking water, and it is 
used by the Council on Wage and Price Stability (CWPS) in its ana-
lyses of the inflation impact of other government regulations . This 
approach is consistent with the policy of the Office of Management 
and Budget that benefits associated with the future savings of  
human life not be discounted in  benefit- cost analyses (OMB, 1972) . 2 
1 Personal communication , July , 1978 . (See also Mishan and Page . )
2 According to one OMB official , discounting the benefits associated
with the saving of future lives is "repugnant to some people" and 
"politically indelicate" . One CWPS official noted that discounting 
these benefits is "politically sensitive , "  and the steady state 
method is used to reflect a "conservative" concern for human health. 
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4. Use the overtaking principle .  The overtaking principle
holds that if, after a certain period of time , all later gener­
ations would prefer the consequences of one decis ion to another 
(the choice being taken by the first generation , e .  g . , installing 
GAG) , that decis ion should be taken in the initial period. A 
cardinal version of this approach is discussed by Weizsacker (1965) 
and Wan (1971) , among others . An ordinal , and independently 
derived ,  version of this principle is developed by Ferej ohn and 
Page (1978) . 
As discussed in the paper by Ferej ohn and Page (1978) , 
adj ustment of the discount rate is not a satis factory resolution 
of the discount rate problem, but the overtaking principle can 
be , when it is appropriate to apply . The appropriate condition 
is that a steady state preference ordering be reached soon in 
terms of generational time (as is the case for the drinking 
water problem) , and under this condition the steady s tate 
comparison and the overtaking principle become the same . 
Consideration of the overtaking principle lends support to 
the s teady state approach taken by both NAS and CWPS and this 
approach will be used here as well .  At the same time calculations 
based on varying discount rates will be o ffered for comparative 
purposes . 
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Quantitative Analys is 
For the discounted benefits and costs , a time-horizon of 100 
years was selected in order to capture fully the s tream of bene­
fits , which was assumed to rise over 70 years and then remain at 
the same level for an infinite length of time . (The difference 
between discounting over 100 years and an infinite period is 
insignificant . )  Costs are in 1978 dollars , corrected for 
inflation. 
The quantitative analysis of benefits will be limited to 
prevented cancer deaths . It mus t be emphasized that this approach 
ignores the several additional benefits of GAG , and thus biases 
the results of the analysis against GAG . The rationale for 
adopt ing this approach is pragmatic . If GAG appears cost-justi­
fied when it is assumed that the only benefit is prevented cancer 
deaths , then it will not be necessary to assess the value of the 
additional benefits . The benefits of reduced anxiety and of 
improvements of the taste and odor of tap water would be 
particularly difficult to measure and the magnitude of the 
additional health benefits is uncertain. Such an assessment would 
be necessary , however, if GAC does not appear cost-justified 
when only prevented cancer deaths are considered . 
In evaluating the benefit of prevented cancer deaths , the 
saving of a human life will not be assigned a dollar value . In­
s tead , for a variety of cancer mortality and discount rate s ,  
the cost o f  GAG per life saved will b e  indicated ,  a llocating the 
total cos ts of GAG to saved l ives . If this cost is less than 
what seems reasonable to spend in saving a human life , then it 
can be said that the benefits exceed the costs, without attempting 
to quantify the other identified benefit s .  
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Use of the risk estimates of 20 to 300 excess cancer deaths 
per million population annually implies that the colillllunity for 
which this analysis mos t  directly app lies is one which depends for 
its water supply on moderately polluted surface water , with resul­
ting TltM levels in the distribution system of approximately 250 
ppb. Colillllunities with lower THM levels could probably meet the 
EPA standard of 100 pg/ l  at considerably lower cos t by adjus tments 
in the method o f  disinfection. Although the epidemiologic studies 
cannot be used to es timate the risk from exposure to current levels 
of synthetic organics (discussed above) , limited risk estimates for 
New Orleans and Miami (see Tables 3 and 4) suggest that these risks 
are in the same range as for the THMs , and may be higher considering 
the presence of numerous carcinogens and suspected carcinogens 
(mutagens and structural analogs of carcinogens) for which the data 
are not available in the form appropriate for risk estimating . 
Furthermore , for conmunities that are required to ins tall GAC only 
for synthetic organics , and not for THMs , benefits will accrue not 
only from reduction of synthetic organics , but also from concurrent 
reductions of THMs and other products of chlorination . 
It was assumed that GAC would reduce the risk of cancer from 
drinking water by 90 percent . It must be noted that there is some 
uncertainty about this estimat e .  It i s  impossible t o  determine the 
reduction in cancer risk that wil l  result from the reduction in 
organic contaminants . From studies conducted by EPA , it is clear 
that GAC is at least 60 percent effective in removing THMs , and 
it is highly effective, in some cases more than 90 percent,  in 
removing industrial chemicals such as polycyclic aromatic hydro­
carbons and polychlorinated pesticides ( e . g . , dieldrin, kepone) 
Since the latter are likely to be more potent carcinogens and muta­
gens than the former ,  it is likely that GAC will reduce the risk of 
cancer by at least 60 p ercent and possibly more than 90 percent. 
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Method of Calculation 
The cos ts of GAC per life saved were calculated according to 
the following step s . First , the total number of excess cancer 
deaths was calculated by applying each risk factor to the total 
population of each representative conununity . For example , for 
the large collDllunity with l . 193 million population , the high cancer 
risk rate of 300 deaths per million annually would yield 300 x 
1 . 19� or 358 , excess deaths annual ly .  Second, the number of 
lives which would be saved annually after the excess cancer rate 
had ceased declining (after 70 years) was calculated as 90% of 
the number of excess deaths , since it was assumed that GAC adsorp ­
tion would eliminate 90% of the excess mortality . For examp le,  
358 x 90% = 322 . 
To calculate the costs of GAC per lire saved in the s teady 
s tate , the number of l ives which would be saved annually after 
70 years was divided into the annual cos t of GAC , disregarding 
expenditures in earlier years when fewer lives per year were 
saved.  To calculate the cos t  per life saved under discounting , 
three additional s teps were taken . 
Firs t ,  for years 71- 100 , the number of lives saved per year 
was the same as under the s teady state . For years 1-70 , it was 
assumed that the number of l ives saved each year would initially 
be small ,  and would rise in the manner described in Appendix E .  
For the large collDllunity , assuming the high rate o f  cancer risk, 
the number of lives saved would be 0 in year 5 ,  51 in year 25 , 
2 7 1  in year 45 , and 322 in year 65 . Second, the cost of GAC for 
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each representative community was discounted using the formula :  
100 
� 
y=l 
Cy 
(l+r) y 
where c is the annual cos t  of GAC , r is the discount rate , and y 
is the year of the time-horizon over which benefits and costs 
were discounted. For example , for the large community the dis­
counted cos t  of $10 , 259 , 800 per year for 100 years , using a 
10% discount rate , was $ 102 , 5 90 , 550 . Third , a cost per life 
saved was chosen so that when discounted back (at r) and sunnned , the 
total would be equal to the discounted costs of GAC . 1 For the 
large community, and assuming the high risk of cancer aad 
a 10% dis count rate , this figure was $545 , 0 0 0 . 
1 This approach incorporates one definition , but not the only 
definition1 of the intertemporal opportuni ty cost per life saved 
( See Mishan and Page , 1979) . 
The calculated sum will differ under various di scount rates 
due to the differing profiles of costs and benefits . 
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VI . RESULTS 
The results of the quantitative analyses for large , medium 
and small communiti es are presented in Table 8 .  The cos t  per life 
saved ranges from about $32 , 000 to $ 17 . 4  million . In 16 out of 36 
cases , the cos t  per life saved is less than $500 , 000 ,  and it is 
about $100 , 000 or less in 8 cases . In 12 cases the cost per life 
exceeds $1 million .  
Due t o  economies o f  scale , the cost per life saved for the 
small community is 1 . 5  to 2 times that for the large community , 
while the cost for the medium community is about 1 . 1  times the 
cost for the large community . The cost per life saved is affected 
by the discount rate more than by the assumption of excess can­
cer mortality. For any assumed level of cancer mortality, applying 
the various discount rates causes the cost per life s aved to vary 
by a factor of 17 to 2 5 . For any selected discount rate , or in the 
steady s tate , the as sumptions of cancer mortality cause the cost
per life saved to vary by only a factor of 12 to 17.  
Large Communities - The cos t  per life saved range s from $32 , 000 
to $8 . 8  million . It ranges from $32 , 000 to $489 , 000 in the steady 
s tate and from about $545 , 0 0 0  to $8 . 8  million under 10% discounting , 
depending on which rate of excess cancer mortality is assumed. For 
the high rate of excess cancer mortality (300 deaths annually per 
million population) , the cost per life saved ranges from $32 , 000 
to $545 , 000 , depending on the discount rate; and for the low rate 
of excess cancer mortality (20 per million) it ranges from $489 , 000 
to $8 . 8  million, depending on the method of discounting . 
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TABLE 8 
ALLOCATION OF COSTS OF GAC TO REDUCED CANCER MORTALITY ALONE 
Excess Cancer Cost Per 
System Size Mortality Rate Steady and (Annual Deaths 
Population 1 Per Million) 2 S tate 3% 77. 10'7. 
Large : 300 $32 $93 $269 $545 
More than 150 $64 $189 $526 $1 , 088 1 , 000 , 000 
20 $489 $ 1 , 434 $4, 147 $8 , 789 
Medium : 300 $37 $ 108 $308 $639 
100 , 000 - 150 $73 $214 $609 $ 1 , 268 1 , 000 , 000 
20 $526 $ 1 , 552 $4, 620 $10 , 19 7  
Small :  300 $57 $166 $476 $ 1 , 000 
75 , 000 - 150 $109 $320 $932 $ 1 , 994 
100 , 000 20 $ 709 $2 , 132 $7 , 206 $17 , 474 
1 
Calculations were based on the following representative systems in 
each size category : Large - population 1 , 193 , 000 , annual GAC costs 
$ 10 . 3  million ; Medium - population 263 , 200 , annual GAC costs $2 . 6  
million ; Small - population 92 , 700 , annual GAC costs $ 1 . 4  million . 
2 Based on THM concentrations of 250 ppb . It is assumed that treat­
ment by GAC adsorption will reduce the excess cancer mortality rate by 
90%. 
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Medium Comtnunities - The cos t  per life saved ranges from 
$37 , 000 to $ 10 million . It ranges from $32 , 000 to $526 , 000 in the 
steady state and from $639 , 000 to $ 10 million under 10% discounting , 
depending on the assumption of excess cancer mortality . For the 
high rate of excess cancer mortality , the cost per life saved 
ranges from $32 , 000 to $639 , 000 , depending on the discount rate , 
while for the low rate of excess cancer mortality, the range is 
from $526 , 000 to $ 10 million . 
Small Communities - The cos t  per life saved ranges from $57 , 000 
to $17 . 4  million . It ranges from $57 , 000 to $709 , 000 in the s teady 
s tate and from $ 1  million to $17 . 4  million under 10% discounting , 
varying with the assumption of excess cancer mortality . Assuming 
the high rate of excess cancer mortality, the cos t per life saved 
varies from $5 7 , 000 to $ 1  million, depending on the discount rate , 
while it varies from $ 709 , 000 to $17 . 4  million for the low assump-
tion of excess cancer mortality . 
These results are depicted graphically in Figures 3 through 5 .  
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Figure 3 
Co m m u n ities w it h  P o p u l ations of M o re t h a n  1 , 000,000: 
Al l ocati o n  of Cost o f  GAC to R e d u cti o n  i n  C a ncer M orta l ity A l o n e  
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Figure 4 
Co m m u nit ies with Popu l at ions of 1 00,000 to 1 ,000,000: 
A l l ocat i o n  of Cost of GAC to R ed u ct i o n  in C a n cer Mo rta l ity A l o n e  
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Figure 5 
Co m m u nities with Populations of 75,000 to 1 00, 000: 
Al locat i o n  of Cost of GAC to Red u ct i o n  in C a ncer M o rtal ity A l o n e  
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VII . DISCUSSION 
Setting aside for the moment consideration of the additional 
benefits of GAC , it can first be considered whether or not GAC is 
cost-justified when it is assumed that the only benefit associated 
with the cost of GAC is reduction in cancer deaths . The cost of 
GAC per life saved is an amount dependent upon a subj ective judg­
ment of the cancer risk associated with organic drinking water 
contaminants , and upon social ,judgments regarding how the interests 
of future generations should be weighed relative to the interests 
of the present generation . In addition to considering these issues , 
decision makers must consider how much should be spent to save a 
human life . 
It is not possible , of course , satisfactorily to value the 
saving of a human life in dollar s , hence it is difficult to determine 
how much is reasonable to spend in saving a life . However ,  because 
policy decisions frequently involve the saving of live s , several 
efforts have been made to determine valuations of human life 
which may serve as a practical guide to decision makers . Three 
principal methods have been employed to determine such valuations . 
(These approaches and their results are more fully elaborated on in 
Appendix D . )  
The willingnes s - to-pay approach i s  mos t  consistent with the 
principle that benefits should be valued by the beneficiary himself , 
and is hence the approach favored by economists . Following 
this approach economists have estimated the extra amount in 
wages paid to workers who accept j ob s  which increase their risk of 
death , taken to be the amount workers would be willing to pay to 
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avoid the risk. This "willingness to pay" for reduced risk is then 
used to determine how much workers collectively would be willing to 
pay to avoid one death among them. Two studies utilizing this 
approach indicated that workers value their lives at $200 , 000 and 
$1 . 5 million , respectively . A similar study indicated that the 
lives of Air Force pilots were valued at $135 , 000- $980 , 00 0 .  The 
figures resulting from these studies can be taken as under­
estimates o f  the cost of cancer mortality because (1) They do
not take into account the amount that the individual ' s  family , 
friends , and society at large would be collectively willing to pay 
to prevent the individual' s death. And ( 2 )  people are concerned 
about the manner of death as well as the time of death. Cancer is 
now the most dread disease and the willingness to pay to decrease 
the risk of accidental death understate s the willingne s s  to pay to 
lower the risk of death by cancer ( see note 1 on page 11) . 
The lost earnings approach measures how much 
a death costs society in lost resources , such as future earning , 
medical care , family expenses , and property and tax effects . In terms 
of medical care and lost earnings alone , a cancer death costs society 
an estimated $70 , 000 ; another estimate , which includes additional 
costs , is approximately $200 , 000 .  Highway and air traffic fatalities 
have been estimated as costing society about $300 , 000 . A maj or obj ec­
tion to this approach is that it reflects the value of an individual ' s  
contribution to the Gross National Product , not the value of his 
life to himself and others .  Surprisingly ,  the lost earnings approach 
and the willingness-to-pay one are not greatly different in their 
e stimates . 
Some observers have interpreted government safety and health 
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regulations as indications of how much society is collectively 
willing to pay to save a human life , although the cost of saving 
a life may not have been explicit in the decision making process . 
Judgments in court cases have also been used as measures of the 
cost of death and inj ury . Such evaluations , which vary a great deal , 
are often considerably higher than the estimates derived from 
willingnes s-to-pay or lost earnings approaches .  
In assessing the reasonableness o f  the cost of GAC per life 
saved , one s tandard of comparison might be the value which indivi­
duals implicitly attach to their lives when undertaking j obs which 
increase their risk of death , i . e . , $200 , 000 to $ 1 . 5  million . 
In the steady s tate , GAC would be j us tified for a risk of 20 
deaths or more. Twenty per million is the risk estimate 
calculated from the accumulated lifetime dose method and thus 
GAC can be j ustified without recourse to the epidemiologic 
data. 
Clearly the s teady state approach , taking intertemporal 
equity into account , is more " favorable" to the future , as 
can be seen in Figures 3 ,  4, and 5 .  The highest curves in the 
figures show net benefits discounted at 10 percent under the 
assumption that cancer prevention is the only benefit . These 
curves can be interpreted as calculations omitting consideration 
of intertemporal equity . The curves labled 3 and 7 percent 
represent intermediate s teps between the two approaches . 
Figures 3 ,  4 ,  and 5 indicate that if three non-conservative 
assumptions are taken together GAC will not be j ustified. The 
non-cons ervative as sumptions are :  little or no weight be given 
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to the epidemiologic evidence ,  so that the risk of cancer is 
assumed low, less than 20 per million ; little or no benefit to 
be assigned to prevention of mutagenic diseas e ,  birth defects ,  
and improvements in taste and odor , so that the cost per life 
saved is totally allocated to cancer prevention ; and no 
consideration be given to intertemporal equity ,  so that cancer 
deaths should be discounted over periods of 40 years and more .  
CWPS and NAS (chapter 8)  employ the first two but not the last 
of the non-conservative assumptions . 
An important issue in the evaluation of GAC is how 
conservative toward the risk of cancer should society be .  We 
believe that a prudent measure of conservatism toward risk 
would place some weight on the epidemiologic evidence and on 
other evidence of the mutagenicity and carcinogenicity of 
non-chloroform, and non-THM organics generally. Nevertheless , 
as j ust  stated above , an important conclusion to emerge from 
the calculations of cost per life saved , under varying assumptions , 
is that justification of GAC need not be based on the epidemi­
ologic evidence at all ,  nor on the inclusion of other benefits 
besides cancer prevention. Application of the accumulated life­
time dose instead of surface area adjustment is a relatively 
small step toward a conservative at�itude toward cancer risk, and 
yet this step is enough to justify GAC . 
But benefits other than cancer prevention should be included 
to the extent they can be quantified, or at least qualitatively 
considered. For example , some sense of the value of benefits of 
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taste and odor control is indicated by the costs of bottled 
water and home filtration devices , which are used primarily to 
produce good tasting drinking water , and which would no longer 
be necessary if GAC adsorption is installed. Compared to the 
annual household costs of GAC of $11-23 , regular household use 
of bottled water costs about $65  to $115 per year , depending on 
geographic region. 1 Home filtration devices cost about $5-12
per year for filter replacement , after initial costs of $20- 40 . 2 
About 40 communities seek good tasting drinking water at lower 
household costs by using GAC in sand filter beds ; the cost of
using GAC for this purpose is about 15-20 percent of the cost 
of using GAC in contactors as a post- filtration adsorbent . 3 
Communities which do not already use GAC for improvements in 
taste and odor may not value these improvements highly enough 
to justify this cos t ,  but probably value these improvements at 
somewhere between zero and this cost .  
Altogether , these additional benefits may have substantial 
value , and some portion of the total costs of GAC should be allo­
cated to securing them. Put differently, the cost of life­
saving benefits alone will comprise only part of the cost 
of GAC . For this reason, the cost of saving a life will 
be less than the costs per life saved discussed above . 
1 Based on consumption of 5 gallons every two weeks (a common mini­
mum order for home delivery) , and per gallon costs of 50-90 cents . 
2 Based on recommended retail prices of 3 maj or brands . 
3 For the three sizes of water treatment plants upon which this 
analysis is based , the annual costs of using GAC in filter beds for 
taste and odor control would b e :  large system (300 mgd) $2 , 342 , 800 ; 
medium system (60 mgd) $574 , 000 ; and small system (20 mgd) $219 , 50 0 .  
These costs include the construction o f  a filter shell , and were 
based on a 3 year carbon replacement cycle.  Source : Environmental 
Protection Agency , Municipal Environmental Research Laboratory , 
Cincinnati , Ohio , personal communication , August 23 , 1978 . 
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If the value of the additional benefits can be assessed relative 
to the value of the total benefits , the cost per life saved could 
be adjusted downward proportionally to determine the cost of saving 
a life by itsel f .  For example, if the additional benefits were 
valued at one third of the total benefits , then the cost of saving 
a life would be one third less than the costs per life saved reported 
above . This type of adjustment will provide a more appropriate basis 
for evaluating the cost of saving of l ife with GAG . 
As discussed above , one of the maj or problems in evaluating 
GAG is the large range of uncertainty of the cancer risk . As 
information concerning the nature of the risk is developing , it 
may at first seem sensible to recommend delay until more is known 
about the risk , in order to decrease the chance that GAG filtration 
plants will not be unnecessarily constructed. If the risk of 
cancer later turns out to be less than 1 or 5 per million , society
would have to live with this mistake for the life of the plant 
(about forty years ) . However , against this irrevers ibility one 
must balance the irreversibilities associated with cancer , 
mutagenic disease , and birth defects . The costs associated with 
these diseases are also largely irreversibl e .  The length o f  
irrevers ibility for cancer is forty o r  more years , due t o  its 
latency period; for mutagenic disease the period of irreversibility 
is in terms of generations . Thus if the true risk turns out to be 
20 or more per million and GAG plants are delayed , society will 
have to live with this mistake , (the unnecessarily caused 
diseases generated during this period of delay) for a considerably 
longer period than the one associated with the irreversibility o f  
GAC plant construction. 
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In the first few years after a decision to build GAC plants , 
in the planning and permit stage , the decision to build is 
reversible at low cost. Once the physical plant is constructed , 
perhaps five or more years after the decision to implement GAC , the 
original decision becomes in part irrevers ible , due to sunk capital 
costs . Operating and maintence costs , howeve r ,  remain reversible. 
In contrast , every year of exposure to carcinogens and mutagens is 
largely irreversible in ultimate effect . Consideration of irreversi­
bility usually suggests delay until more is known lest highly valued 
options be irreversibly foreclosed. In the case o f  drinking water 
treatment , preservation of option suggests earlier introduction of 
preventative measures because the potentially more severe irreversi­
bilities are on the side of cancer and mutation . That i s ,  as more 
information becomes known it is less costly to rectify an irreversible 
mistake of over protection than one of under-protection. 
Taking into account the relative irreversibilities of GAC 
implementation, in terms of planning , operation and maintenance , and 
capital construction , and of cancer and other genetic disease , 
in terms of cure possibilities , Table 8 suggests that a false 
negative is a more costly mistake than a false positive . 1 Social
risk aversion implies a greater avoidance of the potentially more 
costly mistake than indicated by expected value calculations . 
Because the calculations of cost per life saved are based on 
expected values , in this paper2 , consideration of risk aversion 
adds an additional factor in favor of preventative treatment. 
1 A false negative would be to delay treatment when cancer and other 
health costs are very high. A false positive would be to impement GAC 
when cancer and other health costs are very low . 
2 Expected value calculations are also used in CWPS (1978) and NAS (1978�  
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VII I .  SUMMARY AND CONCLUSIONS 
The obj ective of this analysis was to evaluate the bene­
fits of removing organic contaminants from drinking water by 
GAC adsorption. These benefits include : 
(1) prevention of cancer deaths , 
(2) prevention of non- fatal cancer illnesses , 
(3) prevention of mutations and birth defects , 
(4) reduction in the anxiety about the health risks of 
contaminated drinking water , and 
(5)  improvements i n  the taste and odor of tap water. 
In evaluating these benefits , particular emphasis was placed on 
the risk of cancer, the delayed impact of GAC , the prospect o f  
uncertain and irreversible consequences , and the value of saving 
human lives . In part, because of the paucity of data , the only 
benefit of GAC quantitatively considered in the analysis was 
the reduction in cancer deaths . 
In as sessing the cancer risk posed by drinking water con­
taminants , careful thought should be given to the weights placed 
on risk assessments from animal and epidemiologic s tudies . 
Extrapolation from animal models are limited by the fact that 
only a small fraction o f  the organic chemicals in drinking 
water have been characterized toxicologically. Despite this 
limitation , risk estimations using animal data were made for 
three cases : (1) the concentration of carcinogens reported 
by the EPA to be present in New Orleans Drinking Water 
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in a 1974 survey of the lower Mis sissippi , (2) the concentra­
tion of those carcinogens reported by EPA in 1975 to be present 
in Miami drinking water , and (3) a chloro form concentration o f  
2 5 0  ppb . The risk es timates for these three cases were approxi­
mately 23-102 , 19-34 , and 12-20 cancers per million per year , 
respectively . The risk estimation for 250 ppb of chloroform 
(20 cancer/million/yr . )  was taken as the lower bol.llld on the 
risk since it was assumed that in the absence of carcinogens 
of pollution origin , GAC use under the conditions assumed in 
this study (18 min. contact time , two month regeneration frequency) 
would probably only be necess ary to meet EPA ' s proposed THM 
standard of 100 ppb if chloroform levels were higher than the 
200-300 ppb range . 
On the other hand,  well- conducted epidemiologic studies offer the 
potential of comprehensive es timates of risk , s ince they 
measure the human condition , which includes the heterogeneity 
in response and exposure to all chemicals ; animal models must 
be based on only a few of the myriad of organic chemicals 
found in drinking water for which data are available . Based on 
the epidemiologic evidence , the cancer risk posed by organic 
chemicals in drinking water ranged up to approximately 300 
cancer deaths per million per year , which was taken as the 
upper bol.llld on the risk in the benefit- cost analysis . It is 
recognized, however , that epidemiologic studies indicate risks 
for exposures 20 to 40 years (the latency period) prior to 
the study. Hence , the risk from current levels of contamina­
tion may be underes timated by existing s tudies . But there are 
limitations to the existing epidemiologic studies , as discussed 
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above , and it is difficult to know how much weight to place 
on these higher estimates of risk. 
It is also unclear to what extent removing organic 
contaminants from drinking water may reduce non- fatal cancer 
illness and prevent mutations and birth defect s .  I t  is  
difficult to  attach monetary values to  these potential benefits , 
as well as to the benefit of reduced anxiety about the health 
risks of contaminated drinking water and the benefit of improved taste 
and odor of tap water. The difficulties of dealing with these 
benefits prompted the pragmatic approach of first examining 
the cost-justification of GAC under the assumption that the 
only benefit is reduced cancer mortality. 
Since the cost of GAC (on a per-gallon basis) will differ 
significantly for communities of varying sizes the quantitative 
analvsis of benefits and costs (assuming the only benefit was 
reduced cancer mortality) was based on representative communi­
ties in three population size categories : 75 , 000-100 , 000 ; 
100 , 000- 1 , 000 , 000 ; and more than 1 , 000 , 000 . The cost of GAC 
per life saved was determined under three assumptions of the 
cancer risk (i . e .  2 0 , 150 and 300 deaths per million population 
per year) for the steady state and,  by way of comparison , for three 
discount rates (3 , 7  and 10%) . The resulting cost per life saved 
ranged from about $ 3 2 , 0 0 0  to $709 , 0 0 0  on a steady state bas i s .
The costs for Medium and small communities were 1 .1  and 1 . 5-2 times 
as great , respectively , as the cost  for large communities . For
a particular assumption of the cancer risk , the cost varied by
12 -17 fold over the range of discounting approaches ; for a given 
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discounting approach , the cost varied by 17-25 fold over the 
range of risk assumptions . 
To evaluate the cost-justification of GAC when it is 
assumed that the only benefit is reduced cancer mortality , 
benchmarks must be sought regarding how much is reasonable to 
spend in saving a human life . Three possible standards are :  
(1) the $200 , 000- $1 . 5  million range in value of a human life 
implicit in the willingness of workers to accept the risk of 
death in hazardous j obs ; (2) the $200 , 000 that a cancer death 
cost.s society in productive resources , and (3) the $ 1  million 
and larger amounts implicit in other government programs and 
explicit in court settlements .  Each has shortcomings . The 
willingness- to-pay figures do not incorporate the value of the 
individual to his family , friends and society at large ; the 
cost  in productive resources does not include the individual ' s own 
evaluation of the risk of early death by cancer ; and the cost of
government regulations may not have been explicitly taken into 
account when the regulations were adopted. In the absence of 
other criteria , however , these figures have some usefulness .  
Conclusions 
1 .  Using the steady state method of analysis , the 
$ 32 , 0 0 0  to $70 9 1 0 0 0  cost of GAC per life saved is considerably 
less than that of similar health programs undertaken by the 
federal government , also evaluated on a steady state basi s , �nd 
is thus a relative bargain ,  especially for the larger cities 
and for more polluted water sources , where the cost of GAC per 
life saved i s  lowe s t .  
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2 .  Imprecise knowledge about the health risks of organic 
contaminants in drinking water and about the effectiveness of 
GAG in reducing these risks creates uncertainties which weigh 
both for and against GAG . On the one hand , the effectiveness of 
GAG in reducing the health risks posed by organic contaminants 
may not be as great as the 90% assumed in this study , although 
it is unlikely to be less than 60% under the operating assump-
tions used in this analysis . On the other hand the attractiveness  
of GAG is enhanced by  the ·protection it provides against the 
worst possible hazards of organic contaminants ; this is particularly 
so with respect to irreversible damage to the gene poo l ,  which , 
if it were to occur ,  would impose an additional cost on a decision 
not to install GAG today. 
3 .  While i t  i s  difficult t o  know how much weight t o  place 
on each of the two basic approaches to risk assessment , 
extrapolations from animal studies and human epidemiology , a 
decision in favor of GAG and other means of protection against 
toxic chemicals in drinking water does not depend on the 
resolution of this issue . Even if the epidemiologic evidence 
were set aside completely , GAG is justified on the basis of 
animal studies using the accumulated lifetime dose technique . 
A conservative approach toward cancer risk strongly suggests 
placing some weight on the epidemiologic studies . This strengthens 
the decision in favor of GAG and other preventive measures .  
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APPENDIX A 
CARC I NOGrns , MUTAGENS AND PROMOTERS FOUND 
IN UNITED STATES DR I N K I NG WATER 
Carcinogens and Suspect Carci nogens 
Benzo( a) pyrene 
Carbon tetrach l ori de 
Ch l o roform 
V i nyl  chl o ri de 
l ,4-0i oxane 
Methyl i od i de 
ODE 
DDT 
Chlordane 
L i ndane 
Di e 1 d ri n 
Benzene 
Mutagens and Suspect Mutagens 
1 , 1 , 1 -Trich l o roethane 
Bromomethane (methyl b romi de) 
Methyl chl oride 
B romoch l o romethane 
Methy l ene ch l ori de 
Bromoform 
B romodi ch l oromethane 
2-Ch 1 oropropane 
1 ,2- D i ch l o ropropane 
1 -Chl o ropropene 
1 ,2-Di chl oroethane ( recently shown 
to be carc i nogen i c  by NC I )  
B i s  ( 2-ch l oroi sop ropyl ) ethe r  
Chl o rodib romomethane 
1 ,3-Di chl oropropene 
2 ,6-D i n i trotol uene 
List o f  P-romoters 
Ortho�Cresol 
2 , 4-Di methy l phenol 
Phenol 
n-Dodecane 
Eicosane 
2 ,4-Di chl orophenol 
V i ny l i dene ch l o r i de 
Heptach l o r  
1 ,1 ,2-Tri chl oroethane 
1 , 1 , 2-Tri chl oroethy l ene 
Bi s ( 2-ch l o roethy l ) ethe r  
Simazine 
Tetrach l o roethy l ene 
Heptach l or expoxide 
Acryl oni tri l e  
Al dri n 
Buty l  b romi de 
Di ch l oroacetoni tri l e  
Methy l ene bromide 
Chl ordane 
. V i ny l i dene chl oride 
· n-Butyl bromide
B i s ( 2- c h l o roethyl )ether
Acry l oni  tri l e
Benzo ( a ) pyrene
Methyl i od i de 
V i nyl  chl oride 
1 , 3-Butadi ene
1 , 2-Bi s ( ch l oroethoxy ) ethane
Pyrene 
1 , 1 , 2-trichl oroethyl ene
Tetrachl oroethyl ene ( P e rch l o roethy l ene)
n-Decane 
Limonene 
Octadecane 
n-Tetradecane 
n-Undecane 
Source : Nati onal Cancer I n s t i tute , May 1 978 . 
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APPENDIX B 
METHODS OF ESTIMATING CARCINOGENIC RISKS TO HUMANS 
The extent to which cancer is caused by organic contaminants 
in drinking water is extremely difficult , if not impossible , to 
determine . The three principal means of assessing cancer risks 
all have considerable limitations . 
Animal Cancer Tests 
Suspected carcinogens are administered to animals , usually 
rodents , over a period of two to three years . Based on the number 
of tumors resulting and the dose levels , estimates of human risk 
are made . For statistical reasons , higher doses are often re­
quired in animal studies than humans experience .  Therefore , vari­
ous models have been developed for extrapolation of animal risk to 
lower doses , and then estimating from this the risk to humans . Con­
sidering the differences in these methods , in addition to inter­
species susceptibilities to a carcinogen , human risk estimates 
may vary by a factor of 10 or 100 ; there is no certainty that the 
true risk does not lie outside this range . 
Short-Term Tes ts 
A number of short-term tests are used to detect a chemical ' s  
mutagenicity . These methods usually examine the effects on animal 
cells , fruit flies or bacteria .  Comparison o f  bacterial tests to 
animal cancer tests shows that , with few exceptions , the detected 
mutagens are also carcinogens . Although the potency exhibited in 
both tests appears to be related (Ames , 1977) , short-term tests are 
presently used for qualitative , but not quantitative , purposes . 
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Epidemiologic Studies 
Epidemiologic studies relate the incidence of human disease to 
known or suspected causal factors . There are two types of studies .  
Analytic (case control or cohort) studies compare a group of indi­
viduals with the disease being studied to a group of similar indi­
viduals without the disease , matching individuals with similar 
characteristics on a case by case basis . Ecologic (whole population) 
studies compare population groups without matching on an indivi­
dual basis . 
Ecologic studies are primarily used for the generation of hypo­
theses concerning the association of drinking water contaminants and 
cancer . Although relevant factors such as occupation , age , sex 
and ethnic group can be entered into the calculus , these determi­
nations are not made at the individual level ,  and quantification 
of the excess risk due to drinking water remains imprecise . 
Quantifying exces s  cancer rates on the basis  of ecologic studies 
is ,  generally not an accepted practice . In the absence of more 
precise data , however, such calculations have some utility . 
Excess cancer risks can be quantified from analytic studies , 
s ince individual determinations of relevant factors are made . Only 
one such study has been completed which associates drinking water 
contaminants with GI and UT cancer (Alvanj a ,  et al . ,  1977) . Even 
these types of studies , however , cannot control for all the poten­
tially relevant factors and must be interpreted with caution . 
It is difficult to know from epidemiologic studies whether the 
observed excess cancer is solely attributable to drinking water 
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contaminants , or whether the effects of these contaminants are 
potentiated by other types of exposures ; e . g ., from food , air pollu­
tion or smoking . Even if other exposures do have influence , it may 
still be the case that removing carcinogens from water will also 
eliminate the excess  cancer risk . 
Another difficulty in quantifying excess cancer risks from epi­
demiologic studies is that cancer is a disease with a typically 
long latency period, generally twenty to thirty years . Any cancer 
observed now may be caused by unknown exposures occurring decades 
prior , and current cancer rates may not reveal the effects of changes 
in exposures to carcinogens that occurred in recent decades . Rela­
ting currently observed cancers to current water quality data can 
involve considerable distortions . 
Confidence in risk estimates based on epidemiologic studies usu­
ally increases the more extensive the analysis , or the greater the 
number of studies conducted .  In the case o f  drinking water , the 
approximately 12 epidemiologic studies are likely to provide a 
more precise estimate of the risk from THMs than would the models 
of extrapolating from animal studies , since only one (chloroform) 
of the THMs has been tested in animals . Furthermore , synergistic 
and promotional effects are not evident from animal cancer tests , 
unlike the results from epidemiologic studies . 
- 65-
Appendix C 
ESTIMATION OF NONFATAL CANCER ILLNESS 
The extent to which cancer illnes s  is nonfatal is reflected 
by the percentage of cancer victims who are still alive ten years 
after detection of the disease, since survival rates tend to 
stabilize between five and ten years after detection . The extent 
of nonfatal gastrointestinal and urinary tract cancer may be 
estimated by applying first incidence rates and then ten-year 
survival rates to the population at risk . Such estimates are 
necessarily imprecise , due to differences in survey methods , 
determinations of the causes of illness ,vari ations in classifi­
cations , and changes over time in incidence rates and in the survi-
val of treated patients . 
Recognizing these limitations , and assuming that recent inci­
dence and survival trends continue , it appears that approximately 
30% of combined GI and UT cancer is nonfatal , or about 60 , 000 of 
the 200 , 000 cases which are newly detected each year . On an annual 
basis , the number of newly detected nonfatal cases is about 50% 
of the number of deaths from these cancer s ,  which is about 115 , 000 . 
In the long run, however , nonfatal illness would be about 40% of 
fatal illness ( i . e . , 60 , 000/ 140 , 000) . The difference between 
annual and long run percentages may be attributed to the limitations 
of the data described above . 
(See table on next page) 
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Gastrointestinal 
Esophagus 
Stomach 
Small Intestine 
Colon 
Rectum 
Liver 
Gallbladder 
Pancreas 
Urinarz Tract 
Bladder 
Kidney 
Total Gastrointes -
tinal and Urinarz 
Tract 
Excluding Small 
Intestine 
TABLE 9 
Annual Incidence 
per 100 , 000 1 Po;eulation , 1969-71  
Total White Black 
74 . 3. 73 . 0  8 4 . 0  
3 . 4  2 . 8  9 . 7  
10 . 5  10 . 0  15 . 2  
1 . 0  1 . 0  1 . 1  
30 . 9  31 . 0  2 7 . 9  
13 . 6  13 . 7  1 1 . 4  
2 . 2  2 . 1  3 . 4  
3 . 0 3 . 0 2 . 2  
9 . 7  9 . 4  13 . 1  
18 . 6  19 . 1  13 . 0  
13 . 2  13 . 6  7 . 9  
5 . 4 5 . 5  5 . 1
92 . 9  92 . 1  9 7 . 0  
9 1 .  9 9 1 . 1  95 . 9  
Ten-Year Survival 
Rate
1960-732 (Percentage) ,  
Total White Black 
- -
3 3 2 
11 11 11 
NA NA NA 
37 40 34 
35 36 23 
3 3 (3) 3 
6 6 (6)  3 
1 1 2 
5 1  5 3  24 
35 35 33 
29 30 19 
1Age-standardized to 1970 population . Source : National Cancer 
Institute,  The Third National Cancer Survez Advanced Three Year Re;eort 
1969-71 Incidence ,  1974 . 
2These are "relative" survival rates , defined as "the ratio of observed
survival rate for the patient group to the rate expected of patients in 
the general population similar with respect to age ,  sex, race and calen­
dar year of observation" . Source :  National Cancer Institute , Cancer 
Patient Survival , Report #5 , 1976 . Survival rates by ethnic group and 
specific site were provided in that document . Survival rates for all 
ethnic groups by site , and for total GI and UT cancer (excluding small
intestine) were calculated by applying the site-specific incidence rates 
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for whites and blacks to the 1970 U . S .  population : white 178 , 098 , 000 , 
and non-white 25 , 138 , 000 (source : U . S .  Bureau of Census , Statistical 
Abstract of the United States , 1977) , and then applying the relevant 
survival rates . 
3Not available . Assumed to be the same as for whites .
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Appendix D 
METHODS FOR VALUING HUMAN LIFE 
This appendix discusses three principal methods which have 
been used to value human life : willingness-to-pay , lost 
earnings, and valuations imp licit in government decisions . 1 
A maj or difficulty in app lying any of these approaches is 
that there is a distinction between ''known" and "statistical" 
lives . The benefit of a life-saving proj ect is that it reduces 
everyone ' s  chance of death ; without the proj ect a certain number 
of unidentified individuals will die . The valuation placed on 
the certain death of unknown individuals is far lower than valua­
tion placed on life once the victim is known . The difference in 
these values is most evident in the legal system (Zamolo , 1977) , 
under which enormous sums of money have been awarded as compen­
sation after the death has occurred. 
Willingness- to-Pay 
Numerous attempts have been made to apply the "willingness ­
to-pay" concept . A direct attempt is t o  ask individuals directly 
how much they would be willing to pay for reductions in the risk of 
early death , or a particularly dreaded manner of death . While
this direct approach has been discussed (Schelling , 1968» a major
obstacle is that individuals cannot conceptualize the small risk 
reductions involved in life-saving pro j ects ; e . g .  from 2 in
100 , 0 00 to 1 in 100 , 0 0 0 .  Another obstacle ari ses in the 
hypothetical nature o f  the question. 
1A good survey can be found in Linnerooth (l975 ) . 
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Another approach has been to study the wage differential 
between risky and nonrisky j obs to determine how a specific reduc­
tion in the risk of death might be valued . The problems here are , 
first ,  that individuals taking such j obs may be less averse to 
risks than the general population and , second , knowing how an 
individual values a risk reduction from 16 to 15 in 100 , 000 yields 
no information about how the individual might value a reduction 
from 3 to 2 in 100 , 000 . These values may not be the same or 
even close. A further complication is that even if the 
reduced risk of future cancer were the same as the reduced risk 
of dying in an industrial accident in a particular year , the fact 
that in the first case the chance of death is far in the future 
makes comparisons to the latter valuation problematical (Freeman , in 
press) . 
The value of risk reduction to the individual worker , as 
reflected in wage differentials , has been used to determine how 
much workers collectively would be willing to pay to avoid the 
death of one among them (in the statistical sense) . The best 
example of such a s tudy , that of Thaler and Rosen in 1973 , deter­
mined that individuals value a risk reduction of . 00 1  at $200 , 
thus implying that life is worth about $200 , 000 (Rhoads , 19 78) . 
A s imilar study found that a risk reduction from 16 to 8 in 
100 , 000 was valued at $120 , implying a valuation of $ 1 . 5  million 
per life ( Smith , 1976) . In a 196 3  s tudy of flight pay for U . S . 
Air Force captains , Carlson determined that the implied valuation 
of a pilot ' s  life was between $135 , 000 and $980 , 000 , depending on 
the type of plane flown (Zeckhauser , 1975) . 
- 70-
Fewer attempts have been made to assess how individuals 
value life itself . In an informal survey, Schelling 
noted that certain professionals value their lives at 10 to 100 
times their annual salary , or at approximately $200 , 000 to 
$3 , 000 , 000 (Schelling, 1968) . In a study of the psychosocial 
costs of cancer , Abt considered the valuation of life in terms 
of the willingness  to pay to keep people alive in nursing homes 
after their economic value to society has been exhausted (Abt , 
1975) . This cost is about $10 , 000 a year for public nursing 
homes , which Abt considered to be the amount society is willing 
to pay to preserve the life of unknown individuals . The cost is 
about $20 , 000 a year for private nursing hbmes which Abt consi­
dered reflective of the family ' s  willingness  to pay .  Abt consi­
dered the value of preventing a cancer death to be the collective 
annual willingness to pay of society, friends and famil� multi­
plied by the average reduction in life expectancy resulting from 
a cancer death. Abt calculated this figure to be about $400 , 00 0 ,  
based on a reduced life expectancy o f  1 0  years . The weaknesses 
of this approach are that the valuation is dependent upon the age 
of the victim and excludes the victim ' s  own willingness  to pay . 
Lost Earninqs1 
The lost earnings approach attempts to assess the 
cost to society in productive resources when one of its members 
dies . These calculations include medical costs , lost earnings and 
insurance payouts . A fundamental obj ection to this approach is its 
1 The term "societal cost" was used by the National Highway 
Traffic Safety Administration, for this approach. 
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close link to the assumption that the value .of an individual is 
his contribution to the Gross National Product . Of the various 
government agencies which utilize these figures in determining 
the benefits of safety projects , at least two emphatically assert 
that these figures are not construed as the value of a human life . 1 
Nevertheless , the association is difficult to avoid . It is perhaps 
reasonable to consider these figures a lower bound on the finan­
cial benefits to society of saving a life , realizing that they 
exclude the valuation placed on life itself . 
The lost productivity of the individual is measured by the 
present discounted value of future earnings which will be lost  
when the individual dies . One objection to this approach is that 
the resulting valuations of life vary with age , sex , occupation , 
and ethnic group . For example,  the figures for housewives are much 
lower than for young executives . 
In applying the lost earnings approach , Cooper and 
Rice concluded that the cost of cancer illness and death, com­
prised of medical costs and lost earnings , was $15-$17 billion in 
1972 dollars (Cooper and Rice , 1976 ) , or $65 , 000 - $76 , 000 per 
death in 1978 dollars . 2 The cost  per death includes the treatment 
costs of cancer survivors , and the higher and lower figures reflect 
the use of different discount rates . In a recent report by the 
1 Mahesh Podar , National Highway Traffic Safety Administration , 
personal communication, May 11 ,  1978 ; Steve Zaidman , Federal 
Aviation Administration , personal communication, May 1 1 ,  1978.  
2 19 78 costs were derived by adj usting for the 59% increase in 
medical costs and the 51% increase in wages from 1972-19 7 8 .  
Source : U . S .  Department o f  Commerce , Bureau o f  Economic Analysis , 
Business  Statistics , 1975 (publ.  1976) , and Survey of Current 
Business 58 (4) 1978 .  
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National Academy of Sciences (NAS , 1978 ) , the Cooper and Rice 
data were adjusted in a manner which combines the cost of death 
and willingness-to-pay approaches .  Indirect costs (business 
taxes , effects o f  property income) were included ,  and compensation 
for being exposed to the risk of cancer was added . The resulting 
figure was approximately $200 , 000 ( $ 150 , 000 when the willingnes s ­
to-pay approach risk compensations were excluded) . 1 
The National Highway Traffic Safety Administration places 
the cost of a traffic fatality at $28 7 , 000 ( 1975 dollars) ,  which 
includes medical costs , lost earnings , insurance payouts , traffic 
delay and other miscellaneous cos ts . 2 
The Federal Aviation Adminis tration measures the cost of an 
air traffic fatality in terms of the insurance payouts resulting 
from court settlements with the families of victims , rather than 
lost earnings . The figure for 1977 is $300 , 000 . 3 
1John Cumberland , University of Maryland, personal communication , 
May 25 , 1978 . 
2u . s .  Department of Transportation , National Highway Traffic 
Safety Administration , 19 75 Societal Costs of Motor Vehicle 
Accidents ,  19 76 . 
3walter Faison , Federal Aviation Administration , personal communi­
cation , May 11,  197 8 .  
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Valuations Implicit in Government Decisions 
A third approach to discovering society ' s  valuation of human 
life is to determine the valuations implicit in government health 
and safety decisions and regulations . The essential weakness 
of this approach is that such decisions are subject to the vagaries 
of the political process ,  resulting in sometimes bizarre impli­
cations , e . g .J Bailey noted that safety decisions in the military 
implied valuations of human life ranging from several million 
dollars to a negative value (Bailey , 1968) . 
Valuations implicit in government regulations are analyzed 
by the Council on Wage and Price Stability (CWPS) while the regu­
lations are in proposed form . The CWPS method of determining 
these valuations when the reduction in deaths will occur over 
time is to determine the cost per life saved in the "steady s tate" 
which will be reached after the transition period during which the 
reduction occur s . For two Occupational Health and Safety Admini­
stration regulations which control exposure to carcinogens , the 
CWPS has estimated the following implicit valuations o f  human 
life : (1)  inorganic arsenic : $1 million - $9 million , and (2)  
coke oven emiss ions : $4 . 5  million - $158 million . 1 
1council on Wage and Price Stability, "Exposure to Coke Oven 
Emiss ions Proposed Regulation" , May 1 1 ,  19 76 , and "Exposure to 
Inorganic Arsenic Proposed Standard" , September 14 , 1976 . 
- 74-
Appendix E 
METHODOLOGICAL APPENDIX 
1 .  Would Decline Over Time , 
In order to determine the cost of GAC per life saved under 
discounting , it is necessary to determine the number of lives which 
would be saved in each year following the installation of GAC . 
Unfortunately, too little is known about the causal processes of 
cancer to make certain statements about how cancer mortality would 
decrease over time following the removal of organic contaminants 
from drinking water . Numerous assumption� had to be made ; it must 
be realized that these assumptions are speculative . 
It was first assumed that cancer rates would continuously decline 
for a period of 70 years , after which persons currently exposed 
to drinking water carcinogens would no longer be living , and 
thus no one would bear an increased risk of cancer . This future 
time during which the excess cancer risk would be fully reduced 
is termed the "steady state" . Seventy years was selected as the 
time necessary to reach the steady s tate because it is consistent 
with the average life expectancy (about 70) . 
It was then assumed that the excess death rate would not de-
crease for several years , which is consistent with the evidence 
that it takes several years after the cessation of cigarette smo-
king for the risk of lung cancer to cease increasing (Peto , 1977) . 
Finally , it was assumed that the excess cancer rate would 
decrease slowly, then rapidly, then slowly . This pattern is con­
sistent with the evidence that cancer risks often appear to 
increase with exposure slowly , then rapidly , then slowly (Peto , 1977) . 
- 75 -
To translate this pattern into numerical terms , this pattern was 
assumed to approximate the cumulative frequency of a normal curve 
with a midpoint of 35 years and a standard deviation of 10 years . 
By using a standard deviation of ten , the first reductions occur­
red after five years , approximately the lag in experiencing a 
change in the risk of lung cancer after stopping smoking . 
Alternative scenarios were considered, but too little infor­
mation exists to put them in quantitative terms . For example , 
if THM levels have increased in recent years such that the effect 
is not yet evident in current cancer rates , it might the the case 
that not removing THMs would cause an increase in the cancer rate , 
and removing them now would not decrease the cancer rate as soon 
as assumed above . However , the number of lives saved would be 
weighed against the increase in cancer mortality which did 'not 
occur , and this number would ultimately rise above the current 
level of excess cancer deaths . The benefits estimated in this s tucty 
would be underestimated .  
Similarly, in the case of synthetic organics ,  removing them 
now might not reduce cancer rates , but prevent an increase in these 
rates . The number of lives saved would be the increase in cancer 
deaths which did not occur . 
2 .  Calculating the Number of Lives Saved for the Representative 
Populations 
Steady State 
The number of lives saved annually in the steady state was 
assumed to be 90% of the excess cancer deaths which were assumed 
to be caused by drinking water contaminants , since it was assumed 
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that GAC would reduce both contaminants and the risk of cancer by 
90% .  The number o f  excess deaths were determined b y  multiplying 
each population size ( 1 , 19 3 , 000 , 263, 200 and 92 , 700) by each 
estimate of the excess mortality rate per million population per 
year (20 , 150  and 300) ; the number of lives saved in the s teady 
state was calculated by multiplying the number of excess deaths 
by 90% . The following results were obtained for the representative 
systems upon which this analysis was based : 
Excess Cancer Number of 
S:z'.:stem Size PoEulation Hortail.t:z'.: !fate Lives Saved 
Large 1, 193 , 000 300 322 
'•150 161 
20 21 
Medium 263 , 200 300 71 
150 36 
20 5 
Small 92 , 700 300 25 
150 13 
20 2 
Over 100 Years 
During the last 30 years of the 100 year time horizon , the 
steady state would have been reached and the number of lives saved 
in each representative population per year would be the same as 
indicated above . For the first 70 years , however , the number of 
lives saved would be increasing from none to the number reached in 
the s teady state , in the pattern described in the previous section . 
To determine the number of lives saved in each of those years , each 
year was converted to its standard deviation from the mean of a normal 
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curve with a midpoint of 35 and a s tandard deviation of ten . For 
exampl e ,  year 25 was - 1 . 0  standard deviations from the mean . 
For each year ' s  standard deviation, the cumulative frequency 
from the normal. table was multiplied by the number of lives which 
would be saved in the steady state . For example , for year 25 
(s tandard deviation of -1 . 0) , the cumulative frequency would be 
0 . 1587 . For the large population , assuming the high (300) rate of 
excess mortality , the number of l ives saved in year 25 would be
0 . 1587  x 322 = 5 1 .  
Presented below are the number o f  lives saved at ten year inter-
vals for the large system, 4sing the high (300) and low (20) risk 
estimates :  
Number of Lives Saved 
Standard Cumulative (High-Risk Rate) (Low-Risk Rate) 
Year Deviation Freguencl 322 21 
5 - 3 . 0  0 . 00 13 0 0 
15 - 2 . 0  0 . 0228 7 0 25 - 1 . 0  0 . 1587  51  3 35 0 . 0  0 . 5000 161 ll 45 1 . 0  0 . 8413 271 18 5 5  2 . 0  0 .  9772 3 15 21  65 3 . 0 0 . 9987 322 21 71-100 - - 322 21 
The number of lives saved over the total 100 year period were 
as follows : 
Excess Cancer Total Number of 
S:z'.:stem Size PoEulation Mortalitl Rate Lives Saved 
Large 1 , 19 3 , 000 300 
150 
20 , 9 3 1  
10 , 465 
20 1 , 36 7  
Medium 263 , 200 300 4 , 613 
150 2 , 340 
20 325 
Small 9 7 , 200 300 1 , 624 
150 845 
20 131 
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